sayacare_log

Hey, User !

Select delivery location

Fill in New Patient Details

Welcome to SayaCare- India's only E-pharmacy that Tests every Batch👋FREE delivery on 1st order — Use coupon: TESTME101

sayacare_logosayacare_logo

Dicyclomine 10 mg + Mefenamic Acid 250 mg | Tablet

Testeddrug image
Testeddrug image
Testeddrug image
Testeddrug image
Testeddrug image

Dicyclomine 10 mg + Mefenamic Acid 250 mg | Tablet

Drug Code: 467

| tablettablet| Pack of 10 tablets
MRP ₹31

₹16

48% off

🔥358 People bought recently

Per unit price

₹ 1.6/tablets

Quality Lab Tested

This batch has been verified!

WHO- GMP

Sourced Medicines

Each Batch Tested

by SayaCare at Govt. Certified NABL

1,00,000+

Trusted customers

Batch Details

Composition

dicyclomine 10 mg + mefenamic acid 250 mg

Batch

35|AD001945

Expiry

March 2028

Brands with same SaltBut mostly higher prices

meftal spas tablet

₹ 52

meftas

₹ 375

ze spas

₹ 14

gefspas

₹ 25

mefamin

₹ 15

ze spas

₹ 64

dimef

₹ 14

mapic spas

₹ 50

ze spas 10 mg 250 mg tablet

₹ 29

spaz

₹ 13

Why Choose SayaCare ?

You pay for the medicine, not the brand name

Same active ingredients

Exact Same Dosage Type

Lab Tested Quality

Transparent Test Report

Batch Details

Composition

dicyclomine 10 mg + mefenamic acid 250 mg

Batch

35|AD001945

Expiry

March 2028

About Dicyclomine 10 mg + Mefenamic Acid 250 mg

Dicyclomine 10 mg + Mefenamic Acid 250 mg tablet is an antispasmodic + non-steroidal anti-inflammatory drug (NSAID) combination. Dicyclomine 10 mg + Mefenamic Acid 250 mg is used to treat conditions like abdominal cramps, menstrual pain, and intestinal spasms. Dicyclomine works by relaxing the muscles of the stomach and intestines, while mefenamic acid reduces pain and inflammation, providing effective relief from cramps and discomfort.  

It is usually taken after food as prescribed by the doctor. Common side effects of Dicyclomine 10 mg + Mefenamic Acid 250 mg include nausea, dry mouth, dizziness, drowsiness, and stomach discomfort. This medicine should be used with caution in patients with stomach ulcers, kidney, liver, or heart problems, and should be avoided during pregnancy unless advised by a doctor. Avoid alcohol, as it may increase the risk of stomach irritation and drowsiness. 

Medicine Highlights

Uses 1. To treat abdominal pain (stomach cramps)  
2. To relieve menstrual pain (period pain)   
Common Side Effects  1. Nausea  
2. Dry mouth  
3. Dizziness  
4. Drowsiness  
5. Stomach pain   
Additional Information 1. Take it exactly as prescribed by your doctor. 
2. Avoid smoking, as it can reduce the medicine’s effect. 
3. Inform your doctor if you have heart, liver, or kidney problems. 
Storage 1. The medicine should be stored at room temperature.
2. Keep away from sunlight and moisture.
3. Keep away from the reach of children
How to Take This MedicineTake this medicine orally with a sip of water. 

Dicyclomine 10 mg + Mefenamic Acid 250 mg Uses

Dicyclomine 10 mg + Mefenamic Acid 250 mg is an Antispasmodic + Non-Steroidal Anti-Inflammatory Drug (NSAID) combination used to treat conditions like: 

  1. Abdominal cramps  
  2. Menstrual pain (period pain)     

Directions for Use

  1. Take Dicyclomine 10 mg + Mefenamic Acid 250 mg exactly as prescribed by your doctor, at the same time each day. 
  2. Do not stop taking Dicyclomine 10 mg + Mefenamic Acid 250 mg without your doctor’s approval, even if you feel better. 
  3. If you forget to take Dicyclomine 10 mg + Mefenamic Acid 250 mg, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose. 

Dicyclomine 10 mg + Mefenamic Acid 250 mg Side Effects

More Common  

  1. Nausea  
  2. Dry mouth  
  3. Dizziness  
  4. Drowsiness  
  5. Stomach discomfort  

Less Common 

  1. Vomiting  
  2. Blurred vision  
  3. Constipation  
  4. Allergic reactions (rash, itching)     

How Dicyclomine 10 mg + Mefenamic Acid 250 mg Works

This medication consists of dicyclomine and mefenamic acid. Dicyclomine is an antispasmodic that relaxes the muscles in the stomach and intestines, reducing cramps. Mefenamic acid is a pain-relieving medicine (NSAID) that reduces inflammation and pain. Together, they provide effective relief from abdominal and menstrual cramps. 

Safety Measures and Warning

Allergic Reactions

If you have any allergy to Dicyclomine 10 mg + Mefenamic Acid 250 mg, inform your doctor before taking this medicine because it may cause reactions like rash, itching, swelling, or breathing difficulty. 

Stomach ulcers

 If you have stomach ulcers or bleeding problems, inform your doctor because Dicyclomine 10 mg + Mefenamic Acid 250 mg can worsen irritation, bleeding, or stomach pain.

Heart disease

 If you have heart problems, inform your doctor because painkillers like mefenamic acid may increase the risk of complications. 

Liver disease

If you have liver problems, inform your doctor because improper digestion and enzyme imbalance may worsen your condition or reduce the effectiveness of the medicine.

Kidney problems

If you have severe kidney disease, inform your doctor because accumulation of certain components may increase side effects.

Pregnancy

If you are pregnant, inform your doctor before using Dicyclomine 10 mg + Mefenamic Acid 250 mg because although generally safe, it should only be used when clearly needed to avoid any possible risk to the baby.

Breastfeeding

 If you are breastfeeding, inform your doctor because it is not clearly known whether Dicyclomine 10 mg + Mefenamic Acid 250 mg passes into breast milk and it may affect the baby.

Dicyclomine 10 mg + Mefenamic Acid 250 mg Interaction with Food Products

Avoid alcohol as it may increase the risk of stomach irritation, bleeding, and drowsiness. Avoid spicy and oily foods as they may worsen stomach discomfort and acidity while taking this medicine. Limit caffeine intake as it may increase stomach irritation. 

Dicyclomine 10 mg + Mefenamic Acid 250 mg Interaction with Other Medications

Avoid taking Dicyclomine 10 mg + Mefenamic Acid 250 mg with the following medicines, as it may increase or decrease the desired effect, or in worse cases, it could be fatal: 

Dicyclomine 10 mg + Mefenamic Acid 250 mg Chemical Structure

IUPAC (International Union of Pure and Applied Chemistry) Name

Dicyclomine:  2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate 

Dicyclomine 10 mg 

Mefenamic Acid: 2-(2,3-dimethylanilino)benzoic acid 

Mefenamic Acid 250 mg

Intake routine/cycle

Daily dose

Take Dicyclomine 10 mg + Mefenamic Acid 250 mg exactly as your doctor recommends. The dose may change based on your condition and how well you respond. Do not take more than prescribed without consulting your doctor.

Missed Dose

If you forget to take your medicine, take the medication as soon as you remember. If it’s nearly time for your next dose, skip the missed one and continue with your regular schedule. Always consult the doctor before making any changes to your dosage. 

Overdose

It is not recommended to take more than the prescribed dose by doctor, as it may cause severe overdose symptoms like nausea, vomiting, headache, tremors, restlessness, and rapid heartbeat.

Storage

  1. Store the medicine at room temperature 
  2. Keep away from sunlight and moisture 
  3. Keep out of reach of children 

FAQ’s

What are the uses of mefenamic acid and dicyclomine HCl tablets? 

This combination is used to relieve pain and abdominal cramps. Mefenamic acid reduces pain and inflammation, while dicyclomine relaxes the muscles of the stomach and intestines. It is commonly used to treat menstrual pain (period cramps) and abdominal colic or spasms. 

What are the side effects of mefenamic acid and dicyclomine HCl tablets? 

 Common side effects include nausea, vomiting, stomach pain, dryness of mouth, dizziness, and drowsiness. Some people may also experience constipation or blurred vision. These are usually mild but should be monitored. 

What are the contraindications of mefenamic acid and dicyclomine HCl tablets? 

This medicine should be avoided in people with allergy to NSAIDs, stomach ulcers, severe kidney or liver problems, glaucoma, or urinary retention. It is also not recommended during late pregnancy and should be used cautiously in elderly patients.

Reference

  1. Dicyclomine Dosage Guide + Max Dose, Adjustments [Internet]. Drugs.com. Available from 
  2. Dicyclomine – Mechanism, Indication, Contraindications, Dosing, Adverse Effect, Interaction, Hepatic Dose | Drug Index | Pediatric Oncall [Internet]. Available from 
  3. Dicyclomine tablets or capsules [Internet]. Cleveland Clinic. Available from 
  4. Dicyclomine: 7 things you should know [Internet]. Drugs.com. Available from 
  5. PubChem. Mefenamic Acid [Internet]. pubchem.ncbi.nlm.nih.gov. Available from 
  6. Mefenamic Acid (Oral Route) Description and Brand Names – Mayo Clinic [Internet]. Available from 
  7. DrugBank. Mefenamic acid [Internet]. go.drugbank.com. 2022. Available from    

Pranathi Chintaluri avatar

Written By-

Pranathi Chintaluri

Medical content writer

Doctor of Pharmacy | 2+ Year experience

Mahak Phartyal avatar

Reviewed By-

Mahak Phartyal

Medical Content writer and reviewer

Bachelors in Pharmacy | 3+ Year experience

Last Updated: 28 Apr 2026

Similar Items

India's OnlyE- Pharmacy
That Tests Every Medicine Batch.

Tested hai, Toh bharosa hai!

Safe medicines

-Rigorously Tested-

Quality Reports

-Full Transparency-

Low Prices

-Save up to 80%-

Home Delivery

-Fast & Reliable-

Disclaimer

All brand names, trademarks, trade dress, logos, and product names of third parties appearing on SayaCare are the property of their respective owners and are protected under applicable intellectual property laws, including the Trade Marks Act, 1999. SayaCare claims no ownership over, or association with, any such third-party intellectual property.

Third-party brand names and trademarks are referenced on this platform for the purposes of product identification and to assist users in locating generic or equivalent alternatives, in accordance with honest commercial practices under the Trade Marks Act, 1999. Such references do not form part of SayaCare's own branding or promotional identity.

SayaCare is an independent platform and is not affiliated with, endorsed by, sponsored by, or acting as an authorised agent or distributor of any brand referenced herein, and makes no such representation to consumers. The appearance of any brand name on this platform does not imply any formal partnership, endorsement, or direct commercial relationship with the respective brand owner.

Where SayaCare provides information on the generic equivalence of any product to a branded medicine, such information is based on publicly available regulatory data, including schedules under the Drugs and Cosmetics Act, 1940, and information published by the CDSCO. Any editorial content, ratings, or commentary represents the independent views of the platform and should not be attributed to any third-party brand. Neither should be construed as a statement regarding a brand's overall performance or reputation.

All information on this platform is for general awareness only and does not constitute medical advice. Users are strongly advised to consult a registered medical practitioner or licensed pharmacist before substituting any branded medicine with a generic alternative or acting on any information available here. SayaCare is not responsible for brand references or opinions expressed by users in reviews or uploaded content, which represent the views of individual users alone. Users are prohibited from uploading content that infringes the intellectual property rights of any third party.

SayaCare respects the intellectual property rights of all brand owners and does not intend to infringe upon any trademark, trade dress, or related right. If you believe any content on this platform infringes your rights, please contact our IP Grievance Officer at [email protected] . All bona fide complaints will be reviewed within 7 business days and appropriate remedial action taken where infringement is established. This mechanism is maintained in accordance with the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Rules, 2021.